Rytelo (imetelstat) - Geron
nuvisertib (TP-3654) - Sumitomo Pharma
bomedemstat (MK-3543) - Merck (MSD)
navtemadlin (KRT-232) - Kartos Therapeutics, Ipsen
Xpovio (selinexor) - Karyopharm
pelabresib (DAK539) - Novartis
elritercept (TAK-226) - Takeda
http://www.ncbi.nlm.nih.gov/pubmed/42692917
 
Akshay Aluri; Ashwin Kishtagari
 
Sep 4, 2026
 
Prev Next